Skip to main content

Passage BIO Inc

For the period ended Sep 30, 2024. Filed Nov 13, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 13, 2024

PASG$3.43-13.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

​​​​
​ · ​ · Page
PART I.​FINANCIAL INFORMATION4
Item 1.​Interim Financial Statements (Unaudited)4
​​Balance Sheets4
​​Statements of Operations and Comprehensive Loss5
​​Statements of Stockholders’ Equity6
​​Statements of Cash Flows8
​​Notes to Unaudited Interim Financial Statements9
Item 2.​Management’s Discussion and Analysis of Financial Condition and Results of Operations29
Item 3.​Quantitative and Qualitative Disclosures About Market Risk45
Item 4.​Controls and Procedures45
PART II.​OTHER INFORMATION46
Item 1.​Legal Proceedings46
Item 1A.​Risk Factors46
Item 2.​Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities99
Item 3.​Defaults Upon Senior Securities99
Item 4.​Mine Safety Disclosures99
Item 5.​Other Information99
Item 6.​Exhibits100
Signatures102
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.